CNN -- The Food and Drug Administration has approved a drug called Epidiolex to help treat epileptic seizures.
It is the first time that the FDA has approved a Cannabis based drug.
Epidiolex is a twice-daily oral medication that can be used for patients two years of age and older, who suffer from two types of Epilepsy. Davert syndrome is a genetic dysfunctin of the brain that begins in the first twelve months of life. Lennox-Gastaut Syndrome causes multiple types of seizures and begins between the ages of three and five years old.
While the drug is made using the CBD, which is a component in Cannabis, it is nonpsychoactive, meaning it doesn't make you high.
However, you can't line up for the drug just quite yet. Marijuana is still classified as a schedule one drug, so the Drug Enforcement Agency and the FDA are going back and forth.
Dr. Sanjay Gupta says, "the DEA probably has to reschedule at least the CBD, if not the entire cannabis plant in order to be this to be marketed and sold in the United States. It's approved, but in order for people to actually use it it's still considered an illegal substance. It's a really weird sort of back-and-forth right now."
- FDA Approves Cannabis Based Drug
- FDA approves first postpartum depression drug
- FDA approves new drug for migraine sufferers
- TSA now permits FDA-approved epilepsy drug containing cannabis on flights
- FDA Approves First Digital Pill
- FDA approves new osteoporosis drug for postmenopausal women
- Exporting Oregon's cannabis
- FDA Approves First Generic Version of the EpiPen
- The Ultimate Base Camp
- The FDA expands recall of blood pressure drugs again